An interventional study of Non-thermal, atmospheric plasma to treat skin lesions and acne and Indirect non-thermal, atmospheric plasma to treat hair loss and acne in Actinic Keratosis, Acne/Rosacea and Verruca Plana, sponsored by The Skin Center Dermatology Group. Status unknown at 1 site in United States. Open to participants aged 4 Years and older. Per ClinicalTrials.gov, last updated 2022-04-12.
Sponsored by The Skin Center Dermatology Group · Not applicable, Interventional, and Treatment
This study examines the efficacy of a non-thermal, atmospheric plasma device in the treatment of skin disorders
The study uses non-thermal atmospheric pressure plasma to treat target conditions. The patients are monitored at set intervals for efficacy and adverse effects using investigator's assessment and imaging techniques
343 studies on the registry are indexed under Keratosis, Actinic; 29 are open to participants now.
This study's planned enrollment of 100 is above the median of 60 across 295 interventional studies indexed under Keratosis, Actinic.
Browse Keratosis, Actinic studies →The Skin Center Dermatology Group is the lead sponsor of 4 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Device treatment
Device: Non-thermal, atmospheric plasma to treat skin lesions and acne
A compound of non-thermal atmospheric plasma and medium is used to treat the target by direct application or by on-site generation of the compound
Device: Indirect non-thermal, atmospheric plasma to treat hair loss and acne
Non-thermal, atmospheric plasma treatment of affected area or lesions using a nanosecond dielectric barrier discharge plasma device
A compound of non-thermal, atmospheric plasma and medium is delivered to or generated at the target area. Plasma is generated using either microsecond dielectric barrier discharge plasma device or PiezoBrush (a helium jet plasma). The medium is an aqueous alcohol solution
Clinical improvement
The outcome is the presence or lack of clinical improvement in the investigator's global assessment and reviewing photo-documentation as well as reflectance confocal microscopy study investigator's global assessment and reviewing photo-documentation
Time frame: 1-12 months
Started Jan 2016 (actual). Primary completion is estimated for Mar 2024, 98 months after the start.
Of 33 interventional studies with no phase under Keratosis, Actinic, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 33. This study's planned 98 months is above that.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The Skin Center Dermatology Group